Milan - Delayed Quote EUR
JOHNSON & JOHNSON (1JNJ.MI)
135.12
-1.08
(-0.79%)
At close: 3:31:54 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
24,783,000
24,266,000
22,791,000
21,194,000
23,410,000
Investing Cash Flow
-18,432,000
-18,599,000
878,000
-12,371,000
-8,683,000
Financing Cash Flow
6,744,000
-3,132,000
-15,825,000
-8,871,000
-14,047,000
End Cash Position
38,568,000
24,105,000
21,859,000
14,127,000
14,487,000
Income Tax Paid Supplemental Data
--
6,714,000
8,574,000
5,223,000
4,768,000
Interest Paid Supplemental Data
--
1,990,000
1,836,000
982,000
990,000
Capital Expenditure
-6,209,000
-6,207,000
-5,013,000
-4,009,000
-3,652,000
Issuance of Capital Stock
--
--
4,241,000
--
--
Issuance of Debt
34,594,000
21,937,000
21,790,000
16,136,000
2,002,000
Repayment of Debt
-13,866,000
-11,886,000
-24,524,000
-8,684,000
-2,992,000
Repurchase of Capital Stock
-3,084,000
-2,432,000
-5,054,000
-6,035,000
-3,456,000
Free Cash Flow
18,574,000
18,059,000
17,778,000
17,185,000
19,758,000
12/31/2021 - 11/28/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
6MK.F Merck & Co., Inc.
71.50
+2.58%
1LLY.MI Eli Lilly and Company
762.70
+2.03%
NONOF Novo Nordisk A/S
61.55
-3.15%
RHHBY Roche Holding AG
39.49
-0.63%
NOV.DE Novo Nordisk A/S
54.36
-1.09%
ROG.SW Roche Holding AG
261.90
-0.15%
AMGN Amgen Inc.
280.84
+0.36%
GILD Gilead Sciences, Inc.
103.17
-2.81%
NOVO-B.CO Novo Nordisk A/S
403.50
-1.61%
NVO Novo Nordisk A/S
62.07
-0.89%